Literature DB >> 9626636

Role of nitric oxide and prostaglandins in mechanically induced bone formation.

J W Chow1, S W Fox, J M Lean, T J Chambers.   

Abstract

We have previously shown that prostaglandins (PG) and nitric oxide (NO) are required in the induction of bone formation by mechanical stimulation. We therefore tested the ability of NO donors, S-nitroso-N-acetyl-D,L-penicillamine (SNAP), and S-nitroso-glutathione (GSNO) to mimic or augment the osteogenic response of bone to a minimal mechanical stimulus. In rats administered vehicle or the vasodilator hydralazine, stimulation of the 8th caudal vertebra increased bone formation. In animals treated with SNAP or GSNO, there was significant potentiation of this osteogenic response. The bone formation rate in nonloaded vertebrae was unaffected by administration of the NO donors. We also found that while inhibition of either PG or NO production at the time of loading caused a partial suppression of c-fos mRNA expression in the loaded vertebrae, administration of indomethacin and NG-monomethyl-L-arginine together markedly suppressed c-fos expression. This suggests that although both PG and NO are required in mechanically induced osteogenesis, they appear to be generated largely independently of each other. Moreover, while exogenous NO potentiates the stimulatory effect of mechanical loading on bone formation, the lack of effect in nonloaded vertebrae suggests that NO is necessary but not sufficient for induction of bone formation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9626636     DOI: 10.1359/jbmr.1998.13.6.1039

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  32 in total

Review 1.  Pathogenesis of postmenopausal osteoporosis.

Authors:  L G Raisz
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

Review 2.  The Key Role of the Blood Supply to Bone.

Authors:  Massimo Marenzana; Timothy R Arnett
Journal:  Bone Res       Date:  2013-09-25       Impact factor: 13.567

3.  A Novel, Direct NO Donor Regulates Osteoblast and Osteoclast Functions and Increases Bone Mass in Ovariectomized Mice.

Authors:  Hema Kalyanaraman; Ghania Ramdani; Jisha Joshua; Nadine Schall; Gerry R Boss; Esther Cory; Robert L Sah; Darren E Casteel; Renate B Pilz
Journal:  J Bone Miner Res       Date:  2016-09-07       Impact factor: 6.741

Review 4.  Mechanisms by which exercise improves bone strength.

Authors:  Charles H Turner; Alexander G Robling
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

Review 5.  Pathogenesis of osteoporosis: concepts, conflicts, and prospects.

Authors:  Lawrence G Raisz
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

6.  The role of osteocytes in bone mechanotransduction.

Authors:  A Santos; A D Bakker; J Klein-Nulend
Journal:  Osteoporos Int       Date:  2009-06       Impact factor: 4.507

7.  Type II cGMP-dependent protein kinase mediates osteoblast mechanotransduction.

Authors:  Hema Rangaswami; Nisha Marathe; Shunhui Zhuang; Yongchang Chen; Jiunn-Chern Yeh; John A Frangos; Gerry R Boss; Renate B Pilz
Journal:  J Biol Chem       Date:  2009-03-11       Impact factor: 5.157

8.  Protein kinase G and focal adhesion kinase converge on Src/Akt/β-catenin signaling module in osteoblast mechanotransduction.

Authors:  Hema Rangaswami; Raphaela Schwappacher; Trish Tran; Geraldine C Chan; Shunhui Zhuang; Gerry R Boss; Renate B Pilz
Journal:  J Biol Chem       Date:  2012-05-04       Impact factor: 5.157

Review 9.  Nitric oxide signaling in mechanical adaptation of bone.

Authors:  J Klein-Nulend; R F M van Oers; A D Bakker; R G Bacabac
Journal:  Osteoporos Int       Date:  2013-12-10       Impact factor: 4.507

Review 10.  Is interaction between age-dependent decline in mechanical stimulation and osteocyte-estrogen receptor levels the culprit for postmenopausal-impaired bone formation?

Authors:  R Sapir-Koren; G Livshits
Journal:  Osteoporos Int       Date:  2012-11-15       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.